Efficacy and Safety of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations
Efficacy and Safety of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations
Active, not recruiting · NCT07054632 · Registry updated 2026-03-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations | Inherited Retinal Dystrophy Associated With RPE65 Mutations | Active, not recruiting | Phase 3 | 2026-03-05 | NCT07054632 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innostellar Biotherapeutics Co.,Ltd | 9 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai General Hospital | Shanghai | China | 35 |
| Southwest Hospital of AMU | Chongqing | China | 1 |
| Tianjin Medical University Ophthalmology Hospital | Tianjin | China | 1 |
| Zhongshan Ophthalmic Center, Sun Yat sen University | Guangzhou | China | 1 |